Doug Brunk is a San Diego-based award-winning reporter who began covering health care in 1991. Before joining the company, he wrote for the health sciences division of Columbia University and was an associate editor at Contemporary Long Term Care magazine when it won a Jesse H. Neal Award. His work has been syndicated by the Los Angeles Times and he is the author of two books related to the University of Kentucky Wildcats men's basketball program. Doug has a master’s degree in magazine journalism from the S.I. Newhouse School of Public Communications at Syracuse University. Follow him on Twitter @dougbrunk.
News
European postmarket trial confirms findings of Disrupt CAD I
SAN FRANCISCO – Based on consistent clinical data to date, coronary intravascular lithotripsy has proven to be a feasible frontline tool for...
News
Dual therapy best for AFib with ACS no matter the treatment strategy
SAN FRANCISCO – The study marks the only trial in the field that included patients with ACS managed medically.
News
Biologics beyond anti-TNF therapies show promise for ulcerative colitis
Long-term rates of colectomy for ulcerative colitis have not declined over a 10-year period.
Article
Don’t let legal considerations drive your decision making about a new job offer
SAN DIEGO – One way to avoid potential legal trouble is to abide by your employer’s rules governing a physician’s interactions with industry.
News
Study aims to define symptoms of Sjögren’s syndrome secondary to SLE
The study is believed to be the first to investigate whether systemic inflammation, as measured by cytokine levels, differs according to the...
News
Longer-lasting neuromodulators coming down the pike
SAN DIEGO – Even with current products, there is often some degree of efficacy well beyond the 3- to 4-month post-injection time point.
News
Early infusion of mononuclear cells may benefit stroke patients
Well-designed RCTs are needed to further assess safety and efficacy of the approach.
News
Subcutaneous vedolizumab effective for maintenance in subset of UC patients
Patients with moderately to severely active UC can transition from intravenous to subcutaneous vedolizumab for maintenance therapy without losing...
News
Three factors predict 6-month mortality in patients with DILI
A web-based calculator is now available for clinicians to use in the clinic.
News
Laser treatment of basal cell carcinoma continues to be refined
In order to determine the mechanism of cell death and to optimize results, Dr. Ortiz said that further studies need to be conducted in vitro and...
News
Wildfire smoke has acute cardiorespiratory impact, but long-term effects still under study
While research advances, the unforgiving wildfire season looms, assuring more destruction of property and threats to cardiorespiratory health.
News
NDMA found in samples of ranitidine, FDA says
According to the Food and Drug Administration,
News
NDMA found in samples of ranitidine, FDA says
The agency is not calling for individuals to stop taking ranitidine at this time.
News
Expert spotlights telltale clinical signs of xeroderma pigmentosum
AUSTIN, TEX. – Referral to a patient support group is key to coping.
Aesthetic Dermatology
Expert shares tips for laser hair removal prior to gender reassignment surgery
SAN DIEGO – Laser hair removal is often delegated to nonphysicians and is the most common cause of lawsuits for laser injury.